RIAZ HAQUE: Open Payments
NPI 1881697852 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 19 payments from 11 companies in 2025. Trend: 2023 $286 · 2024 $592 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $78 |
| Amgen Inc. | 3 | $54 |
| Stryker Corporation | 1 | $48 |
| GlaxoSmithKline, LLC. | 2 | $42 |
| Eisai Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
| Tempus AI, Inc | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
Products named: FARXIGA, Kerendia, MAKO, TRELEGY ELLIPTA, REPATHA, Leqembi, MOUNJARO, FREESTYLE LIBRE 3.
Industry payments across TX — which companies pay providers there.
